FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Phyllis Svingen

Research Profile

Anatomy

Chemicals & Drugs

Procedures

Immunoblotting

Physiology

Concepts & Ideas

Drug Dose Response Relationship

Disorders

Leukemia

Co-author Network

Publications

TOP 3
Meher K Rahman; Phyllis A Svingen; Yuning Xiong; Zeljko Bajzer; Godfrey C Ford; Sahil Khanna; Chetan P Offord; Xuan-Mai T Perrson; William A Faubion
Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease.
Yuning Xiong; Adrienne L Grzenda; Sahil Khanna; Gwen A Lomberk; Olga F Sarmento; Phyllis A Svingen; Raul A Urrutia; William A Faubion
Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner.
Meher K Rahman; Emilie H Midtling; Phyllis A Svingen; Yuning Xiong; Michael P Bell; Jeanne Tung; Tom Smyrk; Larry J Egan; William A Faubion
The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Phyllis Svingen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Meher K Rahman; Phyllis A Svingen; Yuning Xiong; Zeljko Bajzer; Godfrey C Ford; Sahil Khanna; Chetan P Offord; Xuan-Mai T Perrson; William A Faubion
Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease.
Human immunology 2013;74(2):145-50.
2012: Yuning Xiong; Adrienne L Grzenda; Sahil Khanna; Gwen A Lomberk; Olga F Sarmento; Phyllis A Svingen; Raul A Urrutia; William A Faubion
Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner.
The Journal of biological chemistry 2012;287(41):34372-85.
2010: Meher K Rahman; Emilie H Midtling; Phyllis A Svingen; Yuning Xiong; Michael P Bell; Jeanne Tung; Tom Smyrk; Larry J Egan; William A Faubion
The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(12):7247-56.
2007: Michael P Bell; Phyllis A Svingen; Meher K Rahman; Yuning Xiong; William A Faubion
FOXP3 regulates TLR10 expression in human T regulatory cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1893-900.
2005: Scott H Kaufmann; Judith E Karp; Louis Letendre; Timothy J Kottke; Stephanie L Safgren; Jacqueline Greer; Ivana Gojo; Pamela J Atherton; Phyllis A Svingen; David Loegering; Mark R Litzow; Jeff A Sloan; Joel M Reid; Matthew M Ames; Alex A. Adjei; Charles Erlichman
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6641-9.
2004: Phyllis A Svingen; David Loegering; Joe Rodriquez; Xue Wei Meng; Peter W Mesner; Susan Holbeck; Anne Monks; Stan Krajewski; Dominic A Scudiero; Edward A Sausville; John C Reed; Yuri A Lazebnik; Scott H Kaufmann
Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6807-20.
2003: Kimberly R Kalli; Kathryn E Devine; Myles C Cabot; Christina R Arnt; Michael P Heldebrant; Phyllis A Svingen; Charles Erlichman; Lynn C Hartmann; Cheryl A Conover; Scott H Kaufmann
Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines.
Molecular pharmacology 2003;64(6):1434-43.
2002: Benjamin M F Mow; Joya Chandra; Phyllis A Svingen; Christopher G Hallgren; Ellen Weisberg; Timothy J Kottke; Ven L Narayanan; Mark R Litzow; James D Griffin; Edward A Sausville; Ayalew Tefferi; Scott H Kaufmann
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro.
Blood 2002;99(2):664-71.
2002: Timothy J Kottke; April L Blajeski; Xue Wei Meng; Phyllis A Svingen; Sandrine Ruchaud; Peter W Mesner; Scott A Boerner; Kumiko Samejima; Nico Henriquez; Tamie J Chilcote; Janet Lord; Michael Salmon; William C Earnshaw; Scott H Kaufmann
Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells.
The Journal of biological chemistry 2002;277(1):804-15.
2000: Phyllis A Svingen; Judith E Karp; Stan Krajewski; Peter W Mesner; Steven D Gore; PJ Burke; John C Reed; Y A Lazebnik; Scott H Kaufmann
Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.
Blood 2000;96(12):3922-31.
2000: Maria Eugenia Guicciardi; J Deussing; H Miyoshi; Steven F Bronk; Phyllis A Svingen; C Peters; Scott H Kaufmann; Gregory J Gores
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c.
The Journal of clinical investigation 2000;106(9):1127-37.
2000: Alex A. Adjei; JN Davis; Charles Erlichman; Phyllis A Svingen; Scott H Kaufmann
Comparison of potential markers of farnesyltransferase inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2318-25.
2000: Keith C Bible; Roy H Bible; Timothy J Kottke; Phyllis A Svingen; K Xu; Y P Pang; Elisabeth Hajdu; Scott H Kaufmann
Flavopiridol binds to duplex DNA.
Cancer research 2000;60(9):2419-28.
2000: Alex A. Adjei; Charles Erlichman; JN Davis; David L Cutler; Jeff A Sloan; Randolph S Marks; Lorelei J Hanson; Phyllis A Svingen; Pamela J Atherton; W Robert Bishop; Paul Kirschmeier; Scott H Kaufmann
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.
Cancer research 2000;60(7):1871-7.
2000: II Budihardjo; Scott A Boerner; S Eckdahl; Phyllis A Svingen; R Rios; Matthew M Ames; Scott H Kaufmann
Effect of 6-aminonicotinamide and other protein synthesis inhibitors on formation of platinum-DNA adducts and cisplatin sensitivity.
Molecular pharmacology 2000;57(3):529-38.
2000: Keith C Bible; Scott A Boerner; K Kirkland; Kari L Anderl; D Bartelt; Phyllis A Svingen; Timothy J Kottke; Yean K Lee; S Eckdahl; P G Stalboerger; Robert B Jenkins; Scott H Kaufmann
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):661-70.
2000: Phyllis A Svingen; Ayalew Tefferi; Timothy J Kottke; Gurmeet Kaur; Ven L Narayanan; Edward A Sausville; Scott H Kaufmann
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):237-49.
1999: Denise L Walker; Joel M Reid; Phyllis A Svingen; R Rios; Joseph M Covey; M C Alley; M G Hollingshead; II Budihardjo; S Eckdahl; Scott A Boerner; Scott H Kaufmann; Matthew M Ames
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent.
Biochemical pharmacology 1999;58(6):1057-66.
1999: Peter W Mesner; Keith C Bible; LM Martins; Timothy J Kottke; S M Srinivasula; Phyllis A Svingen; Tamie J Chilcote; Guriqbal S Basi; jay tung; Stan Krajewski; John C Reed; E S Alnemri; William C Earnshaw; Scott H Kaufmann
Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile.
The Journal of biological chemistry 1999;274(32):22635-45.
1999: Kumiko Samejima; Phyllis A Svingen; Guriqbal S Basi; T Kottke; Peter W Mesner; L Stewart; F Durrieu; Guy G Poirier; E S Alnemri; J J Champoux; Scott H Kaufmann; William C Earnshaw
Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis.
The Journal of biological chemistry 1999;274(7):4335-40.
1999: Scott H Kaufmann; Phyllis A Svingen
Immunoblot analysis and band depletion assays.
Methods in molecular biology (Clifton, N.J.) 1999;94():253-68.
1999: William A Faubion; Maria Eugenia Guicciardi; H Miyoshi; Steven F Bronk; PJ Roberts; Phyllis A Svingen; Scott H Kaufmann; Gregory J Gores
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.
The Journal of clinical investigation 1999;103(1):137-45.
1998: Alex A. Adjei; Martin Charron; eric rowinsky; Phyllis A Svingen; J Miller; Joel M Reid; Judith Leopold; Matthew M Ames; Scott H Kaufmann
Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):683-91.
1998: Scott H Kaufmann; Judith E Karp; Phyllis A Svingen; Stan Krajewski; PJ Burke; Steven D Gore; John C Reed
Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.
Blood 1998;91(3):991-1000.
1998: S Mullany; Phyllis A Svingen; Scott H Kaufmann; Charles Erlichman
Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity.
Cancer chemotherapy and pharmacology 1998;42(5):391-9.
1998: II Budihardjo; Denise L Walker; Phyllis A Svingen; C A Buckwalter; S Desnoyers; S Eckdahl; Girish M Shah; G G Poirier; Joel M Reid; Matthew M Ames; Scott H Kaufmann
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):117-30.
1997: LM Martins; Peter W Mesner; Timothy J Kottke; Guriqbal S Basi; Sukanto Sinha; jay tung; Phyllis A Svingen; B J Madden; A Takahashi; D J McCormick; William C Earnshaw; Scott H Kaufmann
Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis.
Blood 1997;90(11):4283-96.
1997: Alex A. Adjei; II Budihardjo; Eric K Rowinsky; Timothy J Kottke; Phyllis A Svingen; C A Buckwalter; Louise B. Grochow; Ross C Donehower; Scott H Kaufmann
Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):761-70.
1997: Scott H Kaufmann; Phyllis A Svingen; Steven D Gore; Deborah K Armstrong; Y C Cheng; eric rowinsky
Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells.
Blood 1997;89(6):2098-104.
1997: LM Martins; T Kottke; Peter W Mesner; Guriqbal S Basi; Sukanto Sinha; Normand Frigon; E Tatar; jay tung; K Bryant; A Takahashi; Phyllis A Svingen; B J Madden; D J McCormick; William C Earnshaw; Scott H Kaufmann
Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis.
The Journal of biological chemistry 1997;272(11):7421-30.
1996: Scott H Kaufmann; Steven D Gore; L Letendre; Phyllis A Svingen; Timothy J Kottke; C A Buckwalter; Richard J Jones; Louise B. Grochow; PJ Burke; Ross C Donehower; Eric K Rowinsky
Factors affecting topotecan sensitivity in human leukemia samples.
Annals of the New York Academy of Sciences 1996;803():128-42.
1996: Scott H Kaufmann; D Peereboom; C A Buckwalter; Phyllis A Svingen; Louise B. Grochow; Ross C Donehower; Eric K Rowinsky
Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
Journal of the National Cancer Institute 1996;88(11):734-41.